COVID Vaccine Data Delayed Amid Less Infection Among Trial Participants, But Data Still Expected Next Month - Morgan Stanley

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Go back to COVID Vaccine Data Delayed Amid Less Infection Among Trial Participants, But Data Still Expected Next Month - Morgan Stanley

Moderna (MRNA) Misses Q3 EPS by 16c, Revenues Beat

October 29, 2020 7:48 AM EDT

Moderna (NASDAQ: MRNA) reported Q3 EPS of ($0.59), $0.16 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $157.91 million versus the consensus estimate of $77.51 million.

The Moderna team continued to execute on our plan in the third quarter. We now have... More